Community-acquired Staphylococcus aureus pneumonia following influenza and the choice of empirical antibiotic treatment;Thuis opgelopen pneumonie door Staphylococcus aureus na influenza en de keuze voor empirische antibiotische behandeling

Nederlands Tijdschrift voor Geneeskunde

Volumn 152, Issue 14, 2008, Pages 822-826

  Van Nieuwkoop, C ^a   Bernards, A T ^a   Compier, E A ^a   Elzo Kraemer, C V ^a   Visser, L G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EXOTOXIN; FLUCLOXACILLIN; RIFAMPICIN;

ADULT; ANAMNESIS; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMMUNITY ACQUIRED PNEUMONIA; GRAM STAINING; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PENICILLIN RESISTANCE; PNEUMONIA; STAPHYLOCOCCUS AUREUS;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; COMMUNITY-ACQUIRED INFECTIONS; EXOTOXINS; FATAL OUTCOME; HUMANS; INFLUENZA, HUMAN; LEUKOCIDINS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, STAPHYLOCOCCAL; SPUTUM; STAPHYLOCOCCUS AUREUS;

EID: 42149154526     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Schouten JA, Prins JM, Bonten M, Degener JE, Janknegt R, Hollander JM, et al. Optimaliseren van het antibioticabeleid in Nederland. VIII. Herziene SWAB-richtlijnen voor antimicrobiële therapie bij thuis opgelopen pneumonie. Ned Tijdschr Geneeskd. 2005;149:2495-500.
2. Aleva RM, Boersma WG. Richtlijn 'Diagnostiek en behandeling van "community-acquired" pneumonie' van de Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose. Ned Tijdschr Geneeskd. 2005;149:2501-7.
3. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-50.
4. Graffelman AW, Knuistingh Neven A, Cessie S le, Kroes AC, Springer MP, Broek PJ van den. Pathogens involved in lower respiratory tract infections in general practice. Br J Gen Pract. 2004;54:15-9.
5. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243-7.
6. Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP. Does this patient have influenza? JAMA. 2005;293:987-97.
7. Ewig S, Schlochtermeier M, Göke N, Niederman MS. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest. 2002;121:1486-92.
8. García-Vázquez E, Marcos MA, Mensa J, de Roux A, Puig J, Font C, et al. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch Intern Med. 2004;164:1807-11.
9. Bohte R, Hermans J, Broek PJ van den. Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. 1996;15:201-5.
10. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44 Suppl 2:S27-72.
11. Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M, Benito Y, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science. 2007;315:1130-3.
12. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753-9.
13. Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-32.
14. Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis. 2005;40:100-7.
15. Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol. 2005;43:2384-90.
16. Vonk AG, Vandenbroucke-Grauls CM. Meticillineresistente Staphylococcus aureus (MRSA) in de gemeenschap. Ned Tijdschr Geneeskd. 2007;151:401-7.
17. Flier M van der, Dijk NB van, Fluit AC, Fleer A, Wolfs TF, Gestel JP van. Fatale pneumonie bij een adolescent door thuis opgelopen meticillineresistente Staphylococcus aureus positief voor Panton-Valentine-leukocidine. Ned Tijdschr Geneeskd. 2003;147:1076-9.
18. Degener JE, Neeling AJ de. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. SWAB. Neth Map 2007. Amsterdam: SWAB/RIVM; 2007.
19. González C, Rubio M, Romero-Vivas J, González M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus. A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis. 1999;29:1171-7.
20. Scheetz MH, Wunderink RG, Postelnick MJ, Noskin GA. Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia. Pharmacotherapy. 2006;26:539-50.
21. Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG, Bridges CB, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis. 2006;12:894-9.
22. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. Emergency ID Net Study Group. N Engl J Med. 2006;355:666-74.
23. Denis O, Deplano A, de Beenhouwer H, Hallin M, Huysmans G, Garrino MG, et al. Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J Antimicrob Chemother. 2005;56:1103-6.
24. Witte W, Braulke C, Cuny C, Strommenger B, Werner G, Heuck D, et al. Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis. 2005;24:1-5.
25. Rubinstein E, Cammarata S, Oliphant T, Wunderink R. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Linezolid Nosocomial Pneumonia Study Group. Clin Infect Dis. 2001;32:402-12.
26. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest. 2003;124:1789-97.
27. Wunderink RG, Cammarata SK, Oliphant TH, Kollef MH. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Linezolid Nosocomial Pneumonia Study Group. Clin Ther. 2003;25:980-92.
28. Gauduchon V, Cozon G, Vandenesch F, Genestier AL, Eyssade N, Peyrol S, et al. Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis. 2004;189:346-53.
29. Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2007;195:202-11.